title: Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.
abstract: Currently, there is no proven drug treatment for dry age-related macular degeneration (AMD). Several different treatment strategies are being investigated, including complement inhibition, neuroprotection, and visual cycle inhibitors, and novel clinical trial endpoints are being explored. Studies have identified genetic predispositions for dry AMD associated with complement dysfunction. Consequently, complement-based therapeutic treatment modalities are promising.
authors: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
authors: Zohar
authors: Z
authors: Yehoshua
authors: Philip J
authors: PJ
authors: Rosenfeld
authors: Thomas A
authors: TA
authors: Albini